Royal Bank of Canada Increases Bausch + Lomb (NYSE:BLCO) Price Target to $23.00
Bausch + Lomb (NYSE:BLCO – Free Report) had its price objective raised by Royal Bank of Canada from $20.00 to $23.00 in a report released on Tuesday morning, Benzinga reports. Royal Bank of Canada ...
Business Wire19d
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third ...
FiercePharma19d
Bausch + Lomb taps broadcaster Erin Andrews to push fast-growing dry eye disease drug
Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the “Miebo ohh yeah” campaign to spread the word about the condition and ...
Business Wire27d
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S ...